Portuguese 
English 
Spanish 
3 min of reading 
0 comments 
With 75 mutations in the Spike protein and confirmed circulation in 23 countries, the subvariant Cicada enters the global radar, increasing fears of new infections and reinforcing the alert about the decline in vaccination
A new subvariant of Covid-19 has begun to gain traction outside Brazil and has caught the attention of scientists due to the high number of mutations. Named Cicada, the BA.3.2 has already been identified in 23 countries and draws attention for its ability to continue circulating in a scenario of accumulated immunity.
So far, the most important aspect for the public is different. The initial data do not indicate an increase in severe cases or hospitalizations, which maintains the understanding that the new lineage follows the pattern seen in the most recent versions of Omicron.
Concern is growing because rapid international circulation often paves the way for new entries into other markets and regions. Therefore, vigilance is focused both on the behavior of the subvariant and on the real protection of the most vulnerable populations.
-
New RG can be delivered by the Post Office in some states, such as São Paulo and Minas Gerais; see how to request it.
-
Homemade mixture of sugar and lemon promises to rejuvenate the skin of the feet, but dermatologists issue a serious warning about the wrong time to use it.
-
He seemed lost, but he got everything right: Charles Ingram “wins” 1 million pounds on Who Wants to Be a Millionaire with a cough code coming from the audience; the production isolates the audio and dismantles the scam.
-
Northeast state provides free tracker for motorcycles in 19 cities and expands program for more drivers.
BA.3.2 emerges as a new branch of Omicron
The BA.3.2 is not an independent variant. It is part of the Omicron family, which continues to undergo changes to maintain active transmission among different populations.
This movement was already expected by experts. Instead of sudden large changes, the virus has begun to advance through sublineages, accumulating alterations that aid in dissemination and circulation.
Spike protein concentrates the most sensitive point of the new lineage
The main difference of Cicada lies in the Spike protein, used by the virus to enter human cells. In this structure, the subvariant gathers about 75 mutations, a volume considered high.
In practice, this may hinder part of the recognition by the immune system. The most likely effect is to facilitate new infections, including in vaccinated individuals or those who have previously been in contact with the virus, without this automatically meaning more severe disease.
Symptoms remain similar to those of recent versions
The signs observed so far remain close to the most common pattern of Omicron. Fever, sore throat, cough, runny nose, and fatigue continue to be among the described manifestations.
No consistent evidence of new symptoms or more aggressive behavior has emerged. This reinforces the perception that the greater impact may be on contagion rather than a clear worsening of clinical severity.
Vaccines still hold back the advance of severe cases
According to g1, vaccines continue to protect mainly against hospitalizations and deaths, even with the presence of mutations that favor some immune escape.
The central point is that the current subvariants still descend from Omicron. This preserves an important part of the body’s response and helps maintain more solid protection against severe forms for a period that can reach 6 to 12 months after the dose.
Brazil has not yet confirmed official circulation of the subvariant
As of the most recent bulletin cited by experts, there was no official confirmation of the presence of BA.3.2 in the country. Nevertheless, the possibility of its arrival is considered plausible.
The reason is simple. When a lineage shows accelerated international dissemination, the historical trend is to reach new territories in a short time, especially in a scenario of constant mobility between countries.
Decline in vaccination increases risk among vulnerable groups
More than the subvariant itself, the warning signal falls on vaccination coverage. The elderly, young children, and pregnant women remain among the most exposed groups when recent protection falls below what is necessary.
Today, Covid-19 presents behavior similar to that of other seasonal respiratory viruses, but still maintains significant weight in public health. This preserves the risk of pressure on the healthcare system.
The Cicada enters the global map as yet another lineage capable of circulating rapidly and testing accumulated immunity. The immediate impact does not indicate greater severity, but reinforces the need for continuous attention.
With 23 countries already on the radar and 75 mutations in the Spike, the scenario demands careful reading on prevention, vaccination coverage, and epidemiological surveillance. The movement pressures the region.
Seja o primeiro a reagir!